» Articles » PMID: 29172289

Prevalence of Helicobacter Pylori Infection in Dyspeptic Patients in Andkhoy Afghanistan

Overview
Specialty Oncology
Date 2017 Nov 28
PMID 29172289
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The prevalence of Helicobacter pylori (H. pylori) infection is reported to be more than 50% worldwide. It has been associated with peptic ulcer disease, gastric carcinoma, and mucosal-associated lymphoid tissue lymphoma. The seroprevalence of H. pylori varies greatly among societies and geographical locations. The objective of this study was to determine the seroprevalence and factors associated with H. pylori infection among dyspeptic patients in Afghanistan. Materials and Methods: This cross-sectional study was designed to determine the seroprevalence of H. pylori among dyspeptic patients in an outpatient clinic in Andkhoy, Afghanistan from January 2017 to April 2017. Data were obtained from patients using a questionnaire, including socio-demographic data and history of smoking and dyspeptic symptoms. Serum samples were also collected from the patients and tested for H. pylori antibodies using the enzyme-linked immunosorbent assay. Results: A total of 152 patients with dyspepsia were included in the analysis; 59 were men (40.0%), and 93 were women (60.0%). The overall seroprevalence of H. pylori was 75.6%. The predictor of seroprevalence of H. pylori was found to be illiteracy (odds ratio [OR] 4.99, 95% confidence interval [CI] 1.03¬24.17), epigastric pain (OR 12.01, 95% CI 3.56- 40.52), and rural population (OR 9.66, 95% CI 3.36- 27.82). There was an inverse association between employed status and seroprevalence of H. pylori (OR 0.08, 95% CI 0.01- 0.52). Conclusions: The seroprevalence of H. pylori was high among patient with dyspepsia in an outpatient clinic in Afghanistan. Illiteracy, unemployment and rural populations, and epigastric pain were significantly associated with H. pylori infection.

Citing Articles

Seroprevalence of in a population of 15 to 35 years old in Mashhad.

Khoshakhlagh M, Tarahomi M, Asgharian F, Kamali A, Abadi S, Jafarpour K Iran J Microbiol. 2024; 16(6):773-779.

PMID: 39737356 PMC: 11682552. DOI: 10.18502/ijm.v16i6.17255.


Diagnostic value of IgG antibody and stool antigen tests for chronic Helicobacter pylori infections in Ibb Governorate, Yemen.

Al Ofairi B, Saeed M, Al-Qubaty M, Abdulkareem A, Al-Jahrani M Sci Rep. 2024; 14(1):7536.

PMID: 38553516 PMC: 10980813. DOI: 10.1038/s41598-024-58165-w.


A comprehensive study of Helicobacter pylori infection: molecular analysis, antibacterial susceptibility, and histopathological examination.

Buyuk F, Karakaya E, Akar M, Kayman T, Tarhane S, Ozcan H Antonie Van Leeuwenhoek. 2023; 116(12):1261-1273.

PMID: 37603113 DOI: 10.1007/s10482-023-01868-3.


Prevalence of Helicobacter pylori infection among resettled refugees presenting to a family medicine clinic in the United States.

Saif N, Jensen N, Farrar E, Blackstone S, Hauck F Helicobacter. 2022; 27(3):e12894.

PMID: 35484785 PMC: 9286549. DOI: 10.1111/hel.12894.


Detection of Helicobacter pylori by invasive tests in adult dyspeptic patients and antibacterial resistance to six antibiotics, including rifampicin in Turkey. Is clarithromycin resistance rate decreasing?.

Akar M, Aydin F, Kayman T, Abay S, Karakaya E Turk J Med Sci. 2021; 51(3):1445-1464.

PMID: 33631868 PMC: 8283485. DOI: 10.3906/sag-2101-69.


References
1.
Us D, Hascelik G . Seroprevalence of Helicobacter pylori infection in an Asymptomatic Turkish population. J Infect. 1998; 37(2):148-50. DOI: 10.1016/s0163-4453(98)80169-2. View

2.
Trespi E, Broglia F, Villani L, Luinetti O, Fiocca R, Solcia E . Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication. Scand J Gastroenterol. 1994; 29(10):884-8. DOI: 10.3109/00365529409094858. View

3.
Almadi M, Aljebreen A, Tounesi F, Abdo A . Helicobacter pylori prevalence among medical students in a high endemic area. Saudi Med J. 2007; 28(6):896-8. View

4.
Malekzadeh R, Derakhshan M, Malekzadeh Z . Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med. 2009; 12(6):576-83. View

5.
Diaconu S, Predescu A, Moldoveanu A, Pop C, Fierbinteanu-Braticevici C . Helicobacter pylori infection: old and new. J Med Life. 2017; 10(2):112-117. PMC: 5467250. View